Aquestive Therapeutics Inc (AQST) — Cash Flow Quality Index

Latest as of March 2023: 1.09x

Aquestive Therapeutics Inc (AQST) has a Cash Flow Quality Index of 1.09x as of March 2023. Operating cash flow of $8.82 Million exceeds net income of $8.07 Million, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Aquestive Therapeutics Inc to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

1.09x

Operating CF / Net Income

Operating Cash Flow

$8.82 Million

USD

Net Income

$8.07 Million

USD

Data as of

Mar 2023

Most recent filing

Annual Cash Flow Quality Index for Aquestive Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Aquestive Therapeutics Inc. For live market cap and the full company financial profile, see how much is Aquestive Therapeutics Inc worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.